Open Herald: Periodical of Methodical Research

Serum Immunoglobulin A, M, and G Concentrations in Iraqi Pediatric Patients Diagnosed with Nephrotic Syndrome

Ahmed Yaseen AL-Tarboolee

Department of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, Jadriya, Baghdad, Iraq.

Mustafa K. Al-Bayaty

University of Technology-Iraq, Applied Sciences Department, Branch of Chemistry. Baghdad, Iraq

Mohammed S. Ali

University of Technology-Iraq, Applied Sciences Department, Branch of Chemistry. Baghdad, Iraq

Mahmoud H. Khalaf AL-Fahdawi

Department of Plant Biotechnology, College of Biotechnology, Al-Nahrain University, Jadriya, Baghdad, Iraq.

Keywords: Nephrotic Syndrome, renal disease, Immunoglobulin G

---

Abstract

Nephrotic syndrome (NS) represents a significant contributor to the incidence of end-stage renal disease, characterized by symptoms such as edema, proteinuria, hypoalbuminemia, and hyperlipidemia. The syndrome is intricately associated with alterations in the immune response. This research focused on analyzing the serum concentrations of immunoglobulins G (IgG), M (IgM), and A (IgA) in a cohort of Iraqi pediatric patients diagnosed with NS. Blood specimens were obtained from 75 children, aged 2 to 15 years, presenting with newly diagnosed typical NS. The study findings indicated a notable reduction in the average serum IgG level (438.18 mg/dL) among NS patients compared to healthy controls (954.09 mg/dL), alongside a significant elevation in the mean serum IgM level (185.66 mg/dL) relative to controls (111.73 mg/dL). Conversely, serum IgA levels exhibited no significant disparity between NS patients and healthy controls. In conclusion, this investigation underscores a marked association between immunological markers and nephrotic syndrome in Iraqi children. The assessment of immunoglobulin levels, coupled with clinical and biochemical parameters, plays a crucial role in the management of NS. There is increasing interest in extensive studies to demonstrate that low IgG and high IgM levels are sensitive markers of worse outcomes in pediatric patients with NS

---

References

Azat, N. (2012). Evaluation of Serum (immunoglobulin G, M) in children with nephrotic

syndrome relapse. J. Fac. Med. Baghdad, 54(1): 15-17.

Bahbah, M.; El Mashad, G.; Abdelnaby, S. and Azab, H. (2015). Serum immunoglobulin G,

M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. Menoufia

med. J., 28: 431-436.

Bierzynska, A.; Soderquest, K. and Koziell, A. (2015). Genes and Podocytes – New Insights

into Mechanisms of Podocytopathy. Frontiers in endocrinology, 5: 226.

Davin, J. and Rutjes, N. (2011). Nephrotic syndrome in children: from bench to treatment.

Int. J. Nephrol., Article ID 372304, 6 pages.

El-Mashad, G.; Ibreahim, S. and Abdelnaby, S. (2017). Immunoglobulin G and M levels in

childhood nephrotic syndrome: two centers Egyptian study. Electron Physician, 9(2): 3728-

Han, J.; Lee, K.; Hwang, J.; Koh, D. and Lee, J. (2010). Antibody Status in Children with

Steroid-Sensitive Nephrotic Syndrome. Yonsei. Med. J., 51(2): 239-243.

Naseri, M. (2013). Pneumococcal sepsis, peritonitis, and cellulitis at the first episode of

nephrotic syndrome. Iran J. Kidney Dis., 7(5): 404-406.

Pereira, F.; Brito-Melo, G.; Guimarães, F.; Carvalho, T.; Mateo, E. and Simõese, S. (2014).

The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and

experimental studies. Inflamm. Res., 63(1): 1-12.

Rong, C.; Wenyan, L.; Yuanyuan, W. and Jian, G. (2017). Advances and researches in

idiopathic nephrotic syndrome biomarkers. MOJ. Women Health, 5(1): 01-10.

Roy, R.; Roy, E.; Rahman, M. and Hossain, M. (2009). Serum immunoglobulin G, M and

IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. World J.

Pediatric., 5(2): 127-131.

Woof, J. and Russell, M. (2011). Structure and function relationships in IgA. Mucosal

Immunol., 4(6): 590-597.

Youssef, D.; Salam, S. and Karam, R. (2011). Prediction of steroid response in nephrotic

syndrome by humoral immunity assessment. Indian J. Nephrol., 21(3): 186-190. 66: 945–9.